A retrospective study assessing treatment outcomes of pulmonary metastases from head and neck squamous cell carcinoma
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Cetuximab (Primary) ; Nivolumab (Primary) ; Cisplatin; Docetaxel; Fluorouracil; Paclitaxel
- Indications Head and neck cancer; Hypopharyngeal cancer; Laryngeal cancer; Nasopharyngeal cancer; Oropharyngeal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 02 Nov 2021 New trial record